Click to Share

Copd Clinical Study Press Releases

Exclusive News
Topics Locations Industries Dates

By Avail Clinical Research
The primary objective of this study is to evaluate the 24-hour spirometric effect (FEV1) of a new drug over a 12-week treatment period in subjects with COPD.

Page updated every 10 minutes

Like PRLog?
Click to Share